L’ipotesi sulla progettazione dello spazio della chiesa Đurđevi Stupovi

Por Filipović Aleksandra
Publicado em 2009-01-01

I Balcani occidentali tra romanico e bizantino

Por Filipović, Aleksandra
Publicado no Europe in between. Histories, cultures and languages from Central Europe to the Eurasian Steppes (2020)

Lemur tyrosine kinase-3 (LMTK3) in cancer and evolution

Por Stebbing, Justin, Filipović, Aleksandra, Giamas, Georgios
Publicado em 2011

Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells

Por Lombardo, Ylenia, Faronato, Monica, Filipovic, Aleksandra, Vircillo, Valentina, Magnani, Luca, Coombes, R Charles
Publicado em 2014

Breast cancer: Clinical implication

Por Filipović Slađana, Filipović Aleksandra, Stojiljković Vladimir, Mišić Ivana, Vrbić Svetislav, Pejčić Ivica, Stanojević Zorica
Publicado em 2007-01-01

Differential expression of estrogen receptor α, β1, and β2 in lobular and ductal breast cancer

Por Huang, Bo, Omoto, Yoko, Iwase, Hirotaka, Yamashita, Hiroko, Toyama, Tatsuya, Coombes, Raoul Charles, Filipovic, Aleksandra, Warner, Margaret, Gustafsson, Jan-Åke
Publicado em 2014

Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo

Por Lombardo, Ylenia, Filipović, Aleksandra, Molyneux, Gemma, Periyasamy, Manikandan, Giamas, Georgios, Hu, Yunhui, Trivedi, Pritesh S., Wang, Jayson, Yagüe, Ernesto, Michel, Loren, Coombes, R. Charles
Publicado em 2012

AKT and 14-3-3 Regulate Notch4 Nuclear Localization

Por Ramakrishnan, Gopalakrishnan, Davaakhuu, Gantulga, Chung, Wen Cheng, Zhu, He, Rana, Ajay, Filipovic, Aleksandra, Green, Andrew R., Atfi, Azeddine, Pannuti, Antonio, Miele, Lucio, Tzivion, Guri
Publicado no Sci Rep (2015)

PKCα Attenuates Jagged-1-mediated Notch Signaling in ErbB-2 positive Breast Cancer to Reverse Trastuzumab Resistance

Por Pandya, Kinnari, Wyatt, Debra, Gallagher, Brian, Shah, Deep, Baker, Andrew, Bloodworth, Jeffrey, Zlobin, Andrei, Pannuti, Antonio, Green, Andrew, Ellis, Ian O., Filipovic, Aleksandra, Sagert, Jason, Rana, Ajay, Albain, Kathy S., Miele, Lucio, Denning, Mitchell F., Osipo, Clodia
Publicado no Clin Cancer Res (2015)

FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer

Por Francis, Richard E., Myatt, Stephen S., Krol, Janna, Hartman, Johan, Peck, Barrie, McGovern, Ursula B., Wang, Jun, Guest, Stephanie K., Filipovic, Aleksandra, Gojis, Ondrej, Palmieri, Carlo, Peston, David, Shousha, Sami, Yu, Qunyan, Sicinski, Piotr, Coombes, R. Charles, Lam, Eric W.-F.
Publicado em 2009

Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells

Por Filipović, Aleksandra, Lombardo, Ylenia, Fronato, Monica, Abrahams, Joel, Aboagye, Eric, Nguyen, Quang-De, d’Aqua, Barbara Borda, Ridley, Anne, Green, Andrew, Rahka, Emad, Ellis, Ian, Recchi, Chiara, Przulj, Natasa, Sarajlić, Anida, Alattia, Jean-Rene, Fraering, Patrick, Deonarain, Mahendra, Coombes, R. Charles
Publicado no Breast Cancer Res Treat (2014)

Erratum to: Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells

Por Filipović, Aleksandra, Lombardo, Ylenia, Faronato, Monica, Abrahams, Joel, Aboagye, Eric, Nguyen, Quang-De, d’Aqua, Barbara Borda, Ridley, Anne, Green, Andrew, Rahka, Emad, Ellis, Ian, Recchi, Chiara, Przulj, Natasa, Sarajlić, Anida, Alattia, Jean-Rene, Fraering, Patrick, Deonarain, Mahendra, Coombes, R. Charles
Publicado no Breast Cancer Res Treat (2014)